期刊文献+

老年人代谢综合征的流行现状及预后 被引量:14

原文传递
导出
作者 程莹 潘长玉
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2005年第10期947-948,共2页 Chinese Journal of Practical Internal Medicine
  • 相关文献

参考文献15

  • 1Wilson FH,Hariri A,Farhi A,et al.A cluster of metabolic defects caused by mutation in a mitochondrial tRNA.Science,2004,306:1190-1194 被引量:1
  • 2Furukawa S,Fujita T,Shimabukuro M,et al.Increased oxidative stress in obesity and its impact on metabolic syndrome.J Clin Invest,2004,114:1752-1761 被引量:1
  • 3田慧,潘长玉,陆菊明,杜锦,徐向进,曹秀党.老年男性人群2型糖尿病与代谢综合征情况调查[J].中华老年多器官疾病杂志,2002,1(1):19-22. 被引量:23
  • 4Bernardo LW.Subcutaneous and visceral adipose tissue:their relation to the metabolic syndrome.Endocr Rev,2000,21:697-738 被引量:1
  • 5潘长玉,田慧,徐向进,陆菊明.北京军队老年人糖尿病患病率、发病率调查[J].中华老年医学杂志,2003,22(6):364-367. 被引量:43
  • 6Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the Joint National Committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report.JAMA,2003,289:2560-2572 被引量:1
  • 7Ford ES,Giles WH,Dietz WH.Prevalence of the metabolic syndrome among US adults:findings from the Third National Health and Nutrition Examination survey.JAMA,2002,287:356-359 被引量:1
  • 8Alexander CM,Landsman PB,Teutsch SM,et al.NCEP-defined metabolic syndrome,diabetes,and prevalence of coronary heart disease among NHANES Ⅲ participants age 50 years and older.Diabetes,2003,52:1210-1214 被引量:1
  • 9Lee WY,Park JS,Noh SY,et al.Prevalence of the metabolic syndrome among 40698 Korean metropolitan subjects.Diabetes Res Clin Pract,2004,65:143-149 被引量:1
  • 10Thomas GN,Ho SY,Janus ED,et al.The US national cholesterol education programme adult treatment panel Ⅲ (NCEP ATPⅢ)prevalence of the metabolic syndrome in a Chinese population.Diabetes Res Clin Pract,2005,67:251-257 被引量:1

二级参考文献14

  • 1田慧,潘长玉,陆菊明,孔祥涛,陆小平,姚晨,蒋赐恩,邓心新,王淑玉,朱艳,崔岚,王正升.糖代谢异常人群中冠心病、高血压的患病率及危险因素调查[J].中华内科杂志,1996,35(5):306-309. 被引量:18
  • 2[1]Reaven GM. Role of insulin resistance in human disease. Diabetes, 1988, 37:1595-1599. 被引量:1
  • 3[2]Marchesini G, Brizi M, Bianchi G,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabe tes, 2001, 50: 1844-1850. 被引量:1
  • 4[3]Norman RJ, Kidson WJ, Cuneo RC, et al. Metformin and intervention in polycystic ovary syndrome. Endocrine Soci ety of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group. Med J Aust, 2001,174: 580-583. 被引量:1
  • 5[4]Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular mor bidity and mortality associated with the metabolic syn drome. Diabetes Care, 2001, 24: 683-689. 被引量:1
  • 6[8]Groop L, Orho-Melander M. The dysmetabolic syndrome, J Intem Med, 2001, 250: 105-120. 被引量:1
  • 7[9]Wilson SH, Kennedy FP, Garratt KN. Optimisation of themanagement of patients with coronary heart disease and type 2 diabetes mellitus. Drugs Aging, 2001, 18: 325-333. 被引量:1
  • 8WHO. Diabetes Mellitus: report of a WHO study group.Geneva. WHO,1985(Teeh Rep Ster, no 727). 被引量:1
  • 9The Expert Committee on the Diagnosis and the Classification of the Diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care ,1997,20 ; 1183-1197. 被引量:1
  • 10Pan CY, Lu JM, Tian H, et al. Study of the prevalence of diabetes mellitus in adults in the Shougang Corporation in Beijing.Diabet Med, 1996, 13: 663-668. 被引量:1

共引文献64

同被引文献91

引证文献14

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部